Logo image of ARMN

ARIS MINING CORP (ARMN) Stock Fundamental Analysis

NYSEARCA:ARMN - CA04040Y1097 - Common Stock

7.11 USD
+0.08 (+1.14%)
Last: 8/22/2025, 8:04:02 PM
7.12 USD
+0.01 (+0.14%)
After Hours: 8/22/2025, 8:04:02 PM
Fundamental Rating

4

ARMN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. ARMN has a medium profitability rating, but doesn't score so well on its financial health evaluation. ARMN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ARMN had positive earnings in the past year.
In the past year ARMN had a positive cash flow from operations.
ARMN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years ARMN had a positive operating cash flow.
ARMN Yearly Net Income VS EBIT VS OCF VS FCFARMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of ARMN (1.33%) is comparable to the rest of the industry.
The Return On Equity of ARMN (3.29%) is better than 61.54% of its industry peers.
With a decent Return On Invested Capital value of 6.33%, ARMN is doing good in the industry, outperforming 67.95% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ARMN is significantly below the industry average of 12.76%.
Industry RankSector Rank
ROA 1.33%
ROE 3.29%
ROIC 6.33%
ROA(3y)0.71%
ROA(5y)4.01%
ROE(3y)1.68%
ROE(5y)8.18%
ROIC(3y)7.46%
ROIC(5y)12%
ARMN Yearly ROA, ROE, ROICARMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

ARMN has a better Profit Margin (4.94%) than 70.51% of its industry peers.
In the last couple of years the Profit Margin of ARMN has declined.
ARMN has a Operating Margin of 27.27%. This is amongst the best in the industry. ARMN outperforms 80.13% of its industry peers.
ARMN's Operating Margin has declined in the last couple of years.
ARMN has a Gross Margin of 35.19%. This is in the better half of the industry: ARMN outperforms 75.64% of its industry peers.
ARMN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 27.27%
PM (TTM) 4.94%
GM 35.19%
OM growth 3Y-13.31%
OM growth 5Y-7.27%
PM growth 3Y-53.75%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-5.36%
ARMN Yearly Profit, Operating, Gross MarginsARMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

3

2. Health

2.1 Basic Checks

ARMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ARMN has been increased compared to 1 year ago.
ARMN has more shares outstanding than it did 5 years ago.
ARMN has a better debt/assets ratio than last year.
ARMN Yearly Shares OutstandingARMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ARMN Yearly Total Debt VS Total AssetsARMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that ARMN is in the distress zone and has some risk of bankruptcy.
ARMN's Altman-Z score of 1.08 is on the low side compared to the rest of the industry. ARMN is outperformed by 76.28% of its industry peers.
ARMN has a Debt/Equity ratio of 0.59. This is a neutral value indicating ARMN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, ARMN is doing worse than 79.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACC0.63
WACC9.98%
ARMN Yearly LT Debt VS Equity VS FCFARMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.10 indicates that ARMN has no problem at all paying its short term obligations.
The Current ratio of ARMN (2.10) is comparable to the rest of the industry.
ARMN has a Quick Ratio of 1.81. This is a normal value and indicates that ARMN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.81, ARMN perfoms like the industry average, outperforming 54.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.81
ARMN Yearly Current Assets VS Current LiabilitesARMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.13% over the past year.
The Revenue has grown by 19.72% in the past year. This is quite good.
ARMN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.71% yearly.
EPS 1Y (TTM)103.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
Revenue 1Y (TTM)19.72%
Revenue growth 3Y21.98%
Revenue growth 5Y23.71%
Sales Q2Q%73.62%

3.2 Future

The Earnings Per Share is expected to decrease by -5.73% on average over the next years.
Based on estimates for the next years, ARMN will show a quite strong growth in Revenue. The Revenue will grow by 13.50% on average per year.
EPS Next Y22.82%
EPS Next 2Y-27.78%
EPS Next 3Y-27.1%
EPS Next 5Y-5.73%
Revenue Next Year-3.43%
Revenue Next 2Y0.95%
Revenue Next 3Y4.05%
Revenue Next 5Y13.5%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ARMN Yearly Revenue VS EstimatesARMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
ARMN Yearly EPS VS EstimatesARMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -2 -4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.94, the valuation of ARMN can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ARMN indicates a rather cheap valuation: ARMN is cheaper than 92.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, ARMN is valued rather cheaply.
ARMN is valuated correctly with a Price/Forward Earnings ratio of 12.63.
ARMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ARMN is cheaper than 70.51% of the companies in the same industry.
ARMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.82.
Industry RankSector Rank
PE 10.94
Fwd PE 12.63
ARMN Price Earnings VS Forward Price EarningsARMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

78.85% of the companies in the same industry are more expensive than ARMN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.85
ARMN Per share dataARMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

ARMN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as ARMN's earnings are expected to decrease with -27.10% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y-27.78%
EPS Next 3Y-27.1%

0

5. Dividend

5.1 Amount

ARMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARIS MINING CORP

NYSEARCA:ARMN (8/22/2025, 8:04:02 PM)

After market: 7.12 +0.01 (+0.14%)

7.11

+0.08 (+1.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-10 2025-11-10/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.22B
Analysts82
Price Target10.29 (44.73%)
Short Float %2.21%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.47%
Min EPS beat(2)-24.59%
Max EPS beat(2)-6.35%
EPS beat(4)0
Avg EPS beat(4)-30.87%
Min EPS beat(4)-47.01%
Max EPS beat(4)-6.35%
EPS beat(8)0
Avg EPS beat(8)-37.5%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.65%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-3.93%
Revenue beat(4)0
Avg Revenue beat(4)-4.95%
Min Revenue beat(4)-5.9%
Max Revenue beat(4)-3.93%
Revenue beat(8)0
Avg Revenue beat(8)-6.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.67%
PT rev (3m)13.19%
EPS NQ rev (1m)36.17%
EPS NQ rev (3m)120.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.94
Fwd PE 12.63
P/S 2.17
P/FCF N/A
P/OCF 6.44
P/B 1.44
P/tB 1.44
EV/EBITDA 7.85
EPS(TTM)0.65
EY9.14%
EPS(NY)0.56
Fwd EY7.92%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)1.1
OCFY15.54%
SpS3.28
BVpS4.92
TBVpS4.92
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.33%
ROE 3.29%
ROCE 8.01%
ROIC 6.33%
ROICexc 7.24%
ROICexgc 7.24%
OM 27.27%
PM (TTM) 4.94%
GM 35.19%
FCFM N/A
ROA(3y)0.71%
ROA(5y)4.01%
ROE(3y)1.68%
ROE(5y)8.18%
ROIC(3y)7.46%
ROIC(5y)12%
ROICexc(3y)9.42%
ROICexc(5y)16.26%
ROICexgc(3y)9.42%
ROICexgc(5y)16.26%
ROCE(3y)9.44%
ROCE(5y)15.19%
ROICexcg growth 3Y-31.05%
ROICexcg growth 5Y-33.95%
ROICexc growth 3Y-31.05%
ROICexc growth 5Y-33.95%
OM growth 3Y-13.31%
OM growth 5Y-7.27%
PM growth 3Y-53.75%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-5.36%
F-Score7
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 2.61
Cap/Depr 548.86%
Cap/Sales 36.08%
Interest Coverage 4.75
Cash Conversion 99.53%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.81
Altman-Z 1.08
F-Score7
WACC9.98%
ROIC/WACC0.63
Cap/Depr(3y)395.74%
Cap/Depr(5y)328%
Cap/Sales(3y)29.9%
Cap/Sales(5y)24.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
EPS Next Y22.82%
EPS Next 2Y-27.78%
EPS Next 3Y-27.1%
EPS Next 5Y-5.73%
Revenue 1Y (TTM)19.72%
Revenue growth 3Y21.98%
Revenue growth 5Y23.71%
Sales Q2Q%73.62%
Revenue Next Year-3.43%
Revenue Next 2Y0.95%
Revenue Next 3Y4.05%
Revenue Next 5Y13.5%
EBIT growth 1Y0.83%
EBIT growth 3Y-4.56%
EBIT growth 5Y1.41%
EBIT Next Year52.77%
EBIT Next 3Y31.28%
EBIT Next 5Y10.1%
FCF growth 1Y67.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y160.03%
OCF growth 3Y20.56%
OCF growth 5Y6.46%